COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery

  • PDF / 759,620 Bytes
  • 10 Pages / 595.276 x 790.866 pts Page_size
  • 21 Downloads / 196 Views

DOWNLOAD

REPORT


REVIEW

COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery Estuardo Behrens 1,2 & Luis Poggi 3,4 & Sergio Aparicio 5 & Pedro Martínez Duartez 6 & Nelson Rodríguez 7 & Natan Zundel 8 & Almino Ramos Cardoso 9 & Diego Camacho 10 & Juan Antonio López-Corvalá 11 & Marcos Leão Vilas-Bôas 5 & Jorge Laynez 12 Received: 14 May 2020 / Revised: 6 August 2020 / Accepted: 6 August 2020 # Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Background COVID-19 pandemic varies greatly and has different dynamics in every country, city, and hospital in Latin America. Obesity increases the risk of SARS-CoV-2 infection, and it is one of the independent risk factors for the most severe cases of COVID-19. Currently, the most effective treatment against obesity available is bariatric and metabolic surgery (BMS), which further resolves or improves other independent risk factors like diabetes and hypertension. Objective Provide recommendations for the resumption of elective BMS during COVID-19 pandemic. Method This document was created by the IFSO-LAC Executive Board and a task force. Based on data collected from a survey distributed to all IFSO-LAC members that obtained 540 responses, current evidence available, and consensus reached by other scientific societies. Results The resumption of elective BMS must be a priority maybe similar to oncological surgery, when hospitals reach phase I or II, treating obesity patients in a NON-COVID area, avoiding inadvertent intrahospital contagion from healthcare provider, patients, and relatives. Same BMS indication and types of procedures as before the pandemic. Discard the presence of SARS-

* Diego Camacho [email protected] Estuardo Behrens [email protected] Luis Poggi [email protected]

Jorge Laynez [email protected] 1

NEW LIFE CENTER, 10 calle 2-45 zona 14. Of. 1202, Guatemala City, Guatemala

2

Bariatric and Metabolic Institute of Guatemala, Guatemala City, Guatemala

3

Department of Surgery Clinica Anglo Americana, Universidad Nacional Mayor de San Marcos, Lima, Peru

4

Peruvian Academy of Surgery, Lima, Peru

5

Clinica los Olivos, Cochabamba Cochabamba, Bolivia

6

Hospital Universitario Austral, Buenos Aires, Argentina

7

Department of Bariatric Surgery, Hospital Puerta de Hierro Andares, Guadalajara, Mexico

8

Buffalo JNMC, Miami, FL, USA

9

Gastro-Obeso-Center Institute of Metabolic Optimization, Sao Pablo, Brazil

10

Department of Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA

11

Hospital Ángeles Tijuana Mexico, Tijuana, Mexico

12

Hospital Roosevelt, Guatemala City, Guatemala

Sergio Aparicio [email protected] Pedro Martínez Duartez [email protected] Nelson Rodríguez [email protected] Natan Zundel [email protected] Almino Ramos Cardoso [email protected] Juan Antonio López-Corvalá [email protected] Marcos Leão Vilas-Bôas [email protected]

OBES SURG

CoV-2 within 72 h prior to surgery. Continu